Injectafer is an injectable intravenous medication manufactured in the United States used to treat patients with Adult Iron Deficiency Anemia. It is administered in two dosages separated by at least 7 days or more.
Researchers and physicians have reported that patients injected with ferric carboxymaltose (FCM), the type of iron used in Injectafer, may not have warned patients of the risk of them getting severe Hypophosphatemia (HPP). HPP is an abnormally low level of phosphate in a person’s blood. Severe HPP can cause severe symptoms such as:
- Muscle wasting and/or weakness
- Severe nausea
- Cardiac arrest and fatal arrhythmias
- Respiratory failure
- Acute hemolytic anemia
- Bone pain and fractures
INSERRA l KELLEY l SEWELL wants you and yours to know that if you have suffered side effects from Injectafer injections, please consult with your physician to find out if you should immediately start taking an alternative medication.
If you or a loved one suffered from severe side effects or death from Injectafer, please call the great mass tort Team at Inserra Kelley Sewell to see whether you might be entitled to compensation.